Admission ECG predicts long-term outcome in acute coronary syndromes without ST elevation

QJM: An International Journal of Medicine

Volumn 99, Issue 9, 2006, Pages 601-607

  Collinson, Julian ^a,b,f   Bakhai, A ^a,c   Taneja, A ^a   Wang, D ^d   Flather, M D ^a,e  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^f CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEATH; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART BUNDLE BRANCH BLOCK; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; Q WAVE; RISK ASSESSMENT; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; T WAVE INVERSION; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 33749635142     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcl079     Document Type: Article

References (30)

1. Hasdai D, Behar S, Wallentin L, et al. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur Heart J 2002; 23:1190-201.
2. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345:494-502.
3. Boersma E, Harrington RA, Moliterno DJ, White H, Theroux P, Van de Werf F, de Torbal A, Armstrong PW, Wallentin LC, Wilcox RG, Simes J, Califf RM, Topol EJ, Simoons ML. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: A meta-analysis of all major randomised clinical trials. Lancet 2002; 359:189-98.
4. Antman EM, Cohen M, Bernink PJL, et al. The TIMI risk score for unstable angina/non-ST elevation MI. A method for prognostication and therapeutic decision making. JAMA 2000; 284:835-42.
5. Eagle KA, Lim MJ, Dabbous OH, et al. A Validated Prediction Model for All Forms of Acute Coronary Syndrome Estimating the Risk of 6-Month Postdischarge Death in an International Registry. JAMA 2004; 291:2727-33.
6. Collinson J, Flather MD, Fox KA, et al. Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK). Eur Heart J 2000; 21:1450-7.
7. Taneja AK, Collinson J, Flather MD, Bakhai A, Perez de Arenaza D, Wang D, Adgey J, Fox KAA. Mortality following non-ST elevation acute coronary sydrome: 4 years follow-up of the PRAIS UK registry (Prospective Registry of Acute Ischaemic Syndromes in the UK). Eur Heart J 2004; 25:2013-18.
8. Office of National Statistics. Health Statistics Quarterly. HMSO Summer 2004 [http://www.statistics.gov.uk/products/p6725.asp].
9. Kaul P, Fu Y, Chang WC, Harrington RA, Wagner GS, Goodman SG, Granger CB, Moliterno DJ, Van de Werf F, Califf RM, Topol EJ, Armstrong PW; PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization Network. Prognostic value of ST segment, depression in acute coronary syndromes: Insights from PARAGON-A applied to GUSTO-IIb. PARAGON-A and GUSTO IIb Investigators. Platelet IIb/IIIa Antagonism for the Reduction of Acute Global Organization Network. J Am Coll Cardiol 2001; 38:64-71.
10. Eagle KA, Goodman SG, Avezum A, Budaj A, Sullivan CM, Lopez-Senclon J; GRACE Investigators. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: Findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 2002; 359:373-7.
11. Fox KAA, Goodman SG, Klein W, Briegar D, Steg PG, Dabbous O, Avezum A; for the GRACE investigators. Management of acute coronary syndromes. Variations in practice and outcome (Findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2002; 23:1177-89.
12. Yusuf S, Flather M, Pogue J, et al. for OASIS (Organisation to Assess Strategies for Ischaemic Syndromes) Registry. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation. Lancet 1998; 352:507-14.
13. Carruthers KF, Dabbous OH, Flather MD, Starkey I, Jacob A, Macleod D, Fox KA; GRACE Investigators. Contemporary management of acute coronary syndromes: Does the practice match the evidence? The global registry of acute coronary events (GRACE). Heart 2005; 91:290-8.
14. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM; Pravastatin or Atorvastatin Evaluation and infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004; 350:1495-504.
15. Kinlay S, Schwartz GG, Olsson AG, Rifai N, Leslie SJ, Sasiela WJ, Szarek M, Libby P, Ganz P; Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering Study Investigators. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study. Circulation 2003; 108:1560-6.
16. Braunwald E, Antman EM, Brooks EH, et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST elevation myocardial infarction: Executive summary and Recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on management of patients with unstable angina). Circulation 2000; 1102:1193-209.
17. Bertrand ME, Simoons ML, Fox KAA, Wallentin LC, Hamm CW, McFadden E, et al. Management of acute coronary syndromes: Acute coronary syndromes without persistent ST elevation: Recommendations of the Task Force of the European Society of Cardiology. Eur Heart J 2000; 21:1406-32.
18. British Cardiac Society Guidelines and Medical Practice Committee and Royal College of Physicians Clinical Effectiveness and Evaluation Unit. Guideline for the management of patients with acute coronary syndromes without persistent ECG ST segment elevation. Heart 2001; 85:133-42.
19. Gulati M, Patel S, Jaffe AS, Joseph AJ, Calvin JE Jr. Impact of contemporary guideline compliance on risk stratification models for acute coronary syndromes in The Registry of Acute Coronary Syndromes. Am J Cardiol 2004; 94:873-8.
20. Mukherjee D, Fang J, Chetcuti S, Moscucci M, Kline-Rogers E, Eagle KA. Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes. Circulation 2004; 109:745-9.
21. Birkhead JS, Walker L, Pearson M, Weston C, Cunningham AD, Rickards AF; National Audit of Myocardial Infarction Project Steering Group. Improving care for patients with acute coronary syndromes: Initial results from the National Audit of Myocardial Infarction Project (MINAP). Heart 2004; 90:1004-9.
22. Fox KA, Poole-Wilson PA, Henderson RA, Clayton TC, Chamberlain DA, Shaw TR, Wheatley DJ, Pocock SJ; Randomized Intervention Trial of unstable Angina Investigators. Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina. Lancet 2002; 360:743-51.
23. Bavry AA, Kumbhani DJ, Quiroz R, Ramchandani SR, Kenchaiah S, Antman EM. Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non-ST-segment elevation acute coronary syndromes: A meta-analysis and review of the literature. Am J Cardiol 2004; 93:830-5.
24. Kim J, Henderson RA, Pocock SJ, Clayton T, Sculpher MJ, Fox KA; RITA-3 Trial Investigators. Health-related quality of life after interventional or conservative strategy in patients with unstable angina or non-ST-segment elevation myocardial infarction: One-year results of the third Randomized Intervention Trial of unstable Angina (RITA-3). J Am Coll Cardiol 2005; 45:221-8.
25. Bhatt DL, Roe MT, Peterson ED, Li Y, Chen AY, Harrington RA, Greenbaum AB, Berger PB, Cannon CP, Cohen DJ, Gibson CM, Saucedo JF, Kleiman NS, Hochman JS, Boden WE, Brindis RG, Peacock WF, Smith SC; Jr, Pollack CV; Jr, Gibler WB, Ohman EM; CRUSADE Investigators. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: Results from the CRUSADE Quality Improvement Initiative. JAMA 2004; 292:2096-104.
26. Bach RG, Cannon CP, Weintraub WS, DiBattiste PM, Demopoulos LA, Anderson HV, DeLucca PT, Mahoney EM, Murphy SA, Braunwald E. The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes. Ann Intern Med 2004; 141:186-95.
27. Hyde TA, French JK, Wong CK, Edwards C, Whitlock RM, White HD. Associations between ST depression, four year mortality, and in-hospital revascularisation in unselected patients with non-ST elevation acute coronary syndromes. Heart 2003; 89:490-5.
28. Hyde TA, French JK, Wong CK, Straznicky IT, Whitlock RM, White HD. Four-year survival of patients with acute coronary syndromes without ST-segment elevation and prognostic significance of 0.5-mm ST-segment depression. Am J Cardiol 1999; 84:379-85.
29. Holmvang L, Clemmensen P, Lindahl B, Lagerqvist B, Venge P, Wagner G, Wallentin L, Grande P. Quantitative analysis of the admission electrocardiogram identifies patients with unstable coronary artery disease who benefit the most from early invasive treatment. J Am Coll Cardiol 2003; 41:905-15.
30. Kaul P, Newby LK, Fu Y, Hasselblad V, Mahaffey KW, Christenson RH, Harrington RA, Ohman EM, Topol EJ, Califf RM, Van de Werf F, Armstrong PW; PARAGON-B Investigators. Troponin T and quantitative ST-segment depression offer complementary prognostic information in the risk stratification of acute coronary syndrome patients. J Am Coll Cardiol 2003; 41:371-80.